Stocks making the biggest moves midday: MRNA, HOOD, BJ, COIN
Check out some of the companies making the biggest moves midday: BJ’s Wholesale — Shares gained 4% after the wholesale retailer posted better-than-expected results for the second quarter. BJ’s earned $1.36 per share, excluding certain items, on revenue of $6.09 billion. Analysts polled by FactSet expected a profit of $1.17 per share on revenue of $5.97 billion. It also increased its earnings per share guidance for the fiscal year to $4.60 and $4.80 from $4.40 to $4.60. Ross Stores — Shares were up over 4% after the retail company posted second-quarter results that exceeded analyst expectations. Ross Stores also issued third-quarter earnings guidance that outperformed estimates. Crypto-related stocks — The group rose broadly as bitcoin continued its march higher on Friday, with the digital currency on pace to end the week more than 20% higher. Robinhood surged 12%, Coinbase gained more than 8%, and Strategy added 6%. Bitcoin got a boost after the White House hosted crypto leaders and urged Congress to pass the Clarity Act, a bill focused on crypto infrastructure and clearer layout on which federal agencies would regulate crypto. Broadcom — Shares are up nearly 1% after Bloomberg News reported, citing sources, that the semiconductor manufacturer was planning to raise over $60 billion in debt for a deal to support Anthropic. OSI Systems – The maker of electronic systems and components dropped almost 10% after fourth-quarter revenue fell short of expectations. OSI reported adjusted earnings of $3.78 per share on revenue of $484.1 million, while analysts polled by FactSet sought $3.77 per share and $529.7 million. Revenue guidance for the fiscal year ending in June 2027 also narrowly missed the Street’s expectations. The Boston Beer Company – The maker of Twisted Tea dropped 3% after announcing that CFO Diego Reynoso will be leaving the company on Sept. 14. He’ll be joining Ingredion as its new finance chief. O-I Glass – The glass container manufacturer jumped 10%. Citi upgraded shares to buy from neutral and lifted its price target to $9 from $8, suggesting 41% upside from Thursday’s close. Moderna – The biotech stock resumed its winning ways on Friday, popping more than 10%. Shares surged nearly 177% on Wednesday after a cancer vaccine from Merck and Moderna showed positive results in a late-stage trial. Moderna shares took a breather on Thursday as investors locked in gains and sold the stock, pushing it down almost 24%. Merck last traded up 2%. InnovAge – The senior care services provider jumped 2%. KeyBanc upgraded shares to overweight from sector weight after analysts met with management and visited one of InnovAge’s centers. “We believe INNV’s turnaround is complete, yet there remain significant opportunities to optimize operations and accelerate growth,” wrote analyst Matthew Gillmor. Parsons – The tech provider with a focus on national security jumped 4% after Baird lifted its price target to $57 from $48 and upgraded the stock to outperform from neutral. The new price target suggests about 24% upside. — CNBC’s Nick Wells and Darla Mercado contributed reporting.
